Contribution: Industrial Research Assistance Program – Contributions to Firms
Aetonix Systems Inc
$107,000.00
Aetonix aTouchAway virtual care platform
FY 2018-19 · 2018-06-04
Summary
Aetonix is focusing on Simplifying the Complexity of Care at home. Aetonix’s aTouchAway is a secure communication and information sharing platform designed to connect healthcare providers, patients, and family members – on one easy-to-use digital platform.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
For-profit organization
Business Number
827242579
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days. The total amended value is 107,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 59 jours. La valeur totale des modifications est de 107 000 dollars.
Agreement End Date
2018-12-31
Agreement Number
909234
Agreement Start Date
2018-06-04
Agreement Title
Aetonix aTouchAway virtual care platform
Agreement Title (French)
Plate-forme virtuelle de soins Aetonix aTouchAway
Agreement Type
Contribution
Agreement Value
$107,000.00
Amendment Date
2018-08-21
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Aetonix is focusing on Simplifying the Complexity of Care at home. Aetonix’s aTouchAway is a secure communication and information sharing platform designed to connect healthcare providers, patients, and family members – on one easy-to-use digital platform.
Description (French)
Aetonix se concentre sur la simplification de la complexité des soins à domicile. ATouchAway d'Aetonix est une plate-forme de communication et de partage d'informations sécurisée conçue pour connecter les prestataires de soins de santé, les patients et les membres de leur famille sur une plate-forme numérique facile à utiliser.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Ottawa Centre
Federal Riding (French)
Ottawa-Centre
Federal Riding Number
35075
NAICS Code
511211
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
827242579
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Aetonix Systems Inc
Recipient Postal Code
K1Y 2C5
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q2-909234
